Shareholding disclosure
Newron Pharmaceuticals S.p.A.
Collectively declared rate
24.19%
Threshold
Crossed upwards
Timeline
Published
07.05.2014
Transaction
29.04.2014
Voting rights breakdown
Declared beneficial owners · 2
A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.
Notice details
Notification ID
TBE4B00049
Beneficial owner
GEFIM SPA
Declared address
GEFIM SPA, 20122 - Milan
Acquisition by Duba of 145'772 shares in Newron as part of an issue of 1'183'597 new shares in Newron which results in the aggregate number of shares and voting rights held by the group to decrease form 25.38% to 24.19% As of the date of this notice, the Newron shares are held dlrectly by Zambon and Duba Zambon Company S.p.A. Via Lillo del Duca n. 10,20091 - Bresso (Milan), Italy, Registry of Companies of Milan n. 01690280159 ("Zambon") is an entity controlled at 85.92% by GEFIM. DUBA A.B., Arsenalsgatan, No.8 C, 10332, Stockholm, Sweden ("DUBA") is a wholly-owned subsidiary of Investor. On 21 Jan 2013 Zambon and Duba entered into a shareholders agreement relating to their respective stakes in NEwron
insider24.ch
Never miss a market signal again
Need more? Discover the Pro plan